INNOVATE (VATE) Q3 2024 earnings summary

Executive summary

• Q3 2024 consolidated revenue was $242.2 million, down 35.5% year-over-year, mainly due to lower Infrastructure segment revenue, while Life Sciences and Spectrum segments posted strong growth.

• Net loss attributable to shareholders was $15.3 million ($1.18 per diluted share), compared to $7.3 million loss in Q3 2023, reflecting a reverse stock split.

• Adjusted EBITDA was $16.8 million, down from $22.1 million in the prior year period.

• Substantial doubt exists about the company's ability to continue as a going concern due to upcoming debt maturities and cross-default provisions; management is exploring refinancing, asset sales, and capital raising.

• DBM Global achieved $6.2 million net income and $20.9 million Adjusted EBITDA, with margin improvement year-over-year.

Financial highlights

• Infrastructure revenue fell 37% to $232.8 million, driven by project timing and completion of large commercial projects.

• Life Sciences revenue rose 400% to $3 million, led by R2's Glacial FX system sales.

• Spectrum revenue increased to $6.4 million, up $1 million year-over-year, with Adjusted EBITDA improving to $1.7 million from a $300,000 loss.

• Company cash and equivalents were $51 million at quarter end, down from $80.8 million at year-end 2023.

• Total principal outstanding indebtedness was $699.2 million, down $23.6 million from year-end 2023.

Outlook and guidance

• Full-year results expected to be slightly lower than last year, with a lighter second half as previously signaled.

• DBM's backlog remains robust at $1.1 billion, positioning the business well for 2025.

• Management highlights substantial doubt about the company's ability to continue as a going concern due to upcoming debt maturities and cross-default provisions.

• Spectrum segment anticipates further OTA network opportunities and is exploring ATSC 3.0 and 5G broadcast TV.

• R2 Technologies expects continued growth in system sales and utilization.